DUSA PHARMACEUTICALS, INC.
NASDAQ : DUSA

DUSA PHARMACEUTICALS, INC.

June 19, 2008 08:01 ET

DUSA Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference on June 26

WILMINGTON, MASSACHUSETTS--(Marketwire - June 19, 2008) - DUSA Pharmaceuticals, Inc. (NASDAQ GM:DUSA) announced today that Robert F. Doman, President and Chief Executive Officer, will be presenting at the Jefferies 2nd Annual Healthcare Conference on Thursday, June 26, 2008 at 1:00 p.m. Eastern Daylight Time in New York, NY.

Live Audio Webcast

The presentation will be available as a live audio webcast on the Company's website at www.dusapharma.com and a copy of the slide presentation together with the audio will be archived on the Company's website following the presentation.

About DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy (PDT) technology platform, and complementary dermatology products. Levulan PDT is currently approved for the treatment of Grade 1 or Grade 2 actinic keratoses of the face or scalp, and is being studied for the treatment of acne. DUSA's other dermatology products include ClindaReach( and Nicomide®. DUSA is also researching additional indications for internal uses of Levulan PDT. DUSA is based in Wilmington, MA. Please visit the company's website at www.dusapharma.com for more information.

Contact Information

  • DUSA Pharmaceuticals, Inc.
    Shari Lovell
    Director, Shareholder Services
    (978) 657-7500 Ext. 1121
    Website: www.dusapharma.com